Myriad Genetics Inc (MYGN) insider trading
Every open-market stock purchase and sale by Myriad Genetics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $722K over the last 12 months (3 buys).
- Insiders sold $66.8K over the last 12 months (1 sale).
- Last insider buy: Paul Bisaro (Director), $27.6K, 5 months ago.
Last 12 months: insiders bought $722K (3 buys) and sold $66.8K (1 sale). Last close $4.14 on Sep 24, 2026.
Recent MYGN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 21, 2026 | Benjamin Richard Wheeler (CFO) | Sold (not open market) | $10.2K |
| Sep 16, 2026 | Vishal Sikri (VP) | Bought (not open market) | — |
| Sep 3, 2026 | Jennifer Lynne Fox (C-suite exec) | Sold (not open market) | $14.2K |
| Aug 16, 2026 | Benjamin Richard Wheeler (CFO) | Sold (not open market) | $26.5K |
| Jun 11, 2026 | Brian J Donnelly (C-suite exec) | Bought (not open market) | $19.7K |
| Jun 11, 2026 | Samraat S. Raha (CEO) | Bought (not open market) | $13.9K |
| Jun 8, 2026 | Rashmi Kumar (Director) | Sold | $66.8K |
| Jun 4, 2026 | Paul Bisaro (Director) | Bought (not open market) | — |
| Jun 4, 2026 | S. Louise Phanstiel (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Daniel Skovronsky (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Mark Steven Davis (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Lee Nisley Newcomer (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Heinrich Dreismann (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Rashmi Kumar (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Colleen F Reitan (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Raj Jampa (CTO) | Bought (not open market) | — |
| May 14, 2026 | Paul Bisaro (Director) | Bought | $27.6K |
| May 1, 2026 | Brian J Donnelly (C-suite exec) | Sold (not open market) | $269K |
| Apr 14, 2026 | Mark Verratti (COO) | Sold (not open market) | $5.2K |
| Apr 14, 2026 | Dale Muzzey (C-suite exec) | Sold (not open market) | $4.6K |
| Mar 22, 2026 | Mark Verratti (COO) | Sold (not open market) | $9.4K |
| Mar 22, 2026 | Dale Muzzey (C-suite exec) | Sold (not open market) | $9.2K |
| Mar 22, 2026 | Benjamin Richard Wheeler (CFO) | Sold (not open market) | $2.5K |
| Mar 15, 2026 | Dale Muzzey (C-suite exec) | Sold (not open market) | $55.7K |
| Mar 15, 2026 | Mark Verratti (COO) | Sold (not open market) | $42.4K |
Who's trading MYGN
- Benjamin Richard Wheeler, CFO: other filings, last Sep 21, 2026
- Vishal Sikri, VP: other filings, last Sep 16, 2026
- Jennifer Lynne Fox, C-suite exec: other filings, last Sep 3, 2026
- Samraat S. Raha, CEO: bought $200K (1 buy), last Jun 11, 2026
- Brian J Donnelly, C-suite exec: other filings, last Jun 11, 2026
- Rashmi Kumar, Director: sold $66.8K (1 sale), last Jun 8, 2026
- Colleen F Reitan, Director: other filings, last Jun 4, 2026
- Paul Bisaro, Director: bought $27.6K (1 buy), last Jun 4, 2026
- Mark Steven Davis, Director: other filings, last Jun 4, 2026
- Heinrich Dreismann, Director: other filings, last Jun 4, 2026
- Daniel Skovronsky, Director: other filings, last Jun 4, 2026
- Lee Nisley Newcomer, Director: other filings, last Jun 4, 2026
- S. Louise Phanstiel, Director: bought $495K (3 buys), last Jun 4, 2026
- Raj Jampa, CTO: other filings, last Jun 1, 2026
- Dale Muzzey, C-suite exec: other filings, last Apr 14, 2026
Get free alerts when an insider at Myriad Genetics Inc files a new trade →